医学临床研究
  2025年5月9日 星期五           首 页    |    期刊简介    |    编委会    |    投稿指南    |    期刊订阅    |    广告合作    |    留言板    |    联系我们    |    English
医学临床研究  2024, Vol. 41 Issue (4): 579-582    DOI: 10.3969/j.issn.1671-7171.2024.04.028
  论著 本期目录 | 过刊浏览 | 高级检索 |
桂枝甘草汤联合常规西药治疗慢性心力衰竭患者的临床疗效
赵丽晨
天津市公安医院,天津 300040
Clinical Efficacy of Guizhi Gancao Decoction Combined with Conventional Western Medicine in the Treatment of Patients with Chronic Heart Failure
ZHAO Lichen
The Tianjin Public Security Hospital, Tianjin 300040
全文: PDF (1165 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 【目的】探讨桂枝甘草汤联合常规西药治疗慢性心力衰竭(简称心衰)患者的临床疗效。【方法】选择本院收治的102例慢性心衰患者,根据随机数字表法将其分为观察组和对照组,每组51例。对照组采用常规西药治疗,观察组在对照组基础上加用桂枝甘草汤。治疗1个月后,比较两组临床疗效、不良反应发生情况,以及治疗前后实验室指标[高敏C反应蛋白(hs-CRP)、氨基末端B型脑钠肽前体(NT-proBNP)、红细胞分布宽度(RDW)]、中医证候评分、心功能指标[左心室舒张末期内经(LVEDD)、左心室收缩末期内径(LVESD)、左室射血分数(LVEF)]。【结果】观察组患者总有效率明显高于对照组,差异有统计学意义(P<0.05)。治疗后,两组气短心悸、咳嗽咯痰、少气懒言评分均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05);观察组患者NT-proBNP、hs-CRP、RDW水平明显低于治疗前及对照组治疗后(P<0.05);两组患者LVEDD、LVESD低于治疗前,LVEF高于治疗前,观察组LVEDD、LVESD低于对照组,LVEF高于对照组,差异有统计学意义(P<0.05)。两组患者不良反应总发生率比较,差异无统计学意义(P>0.05)。【结论】在常规西医治疗的基础上应用桂枝甘草汤治疗慢性心衰,可提高临床治疗效果,改善心功能,安全性高,值得临床推广应用。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
赵丽晨
关键词 心力衰竭/中西医结合疗法慢性病治疗结果    
Abstract:【Objective】To investigate the clinical efficacy of Guizhi Gancao Decoction Combined with conventional western medicine in the treatment of patients with chronic heart failure. 【Methods】A total of 102 patients with chronic heart failure were selected and divided into observation group and control group according to the random number table method, with 51 cases in each group. The control group was treated with conventional western medicine, and the observation group was treated with Guizhi Gancao Decoction on the basis of the control group. After one month of treatment, the clinical efficacy, the occurrence of adverse reactions, and the laboratory indexes [high-sensitivity C-reactive protein (hs-CRP), N-terminal pro brain natriuretic peptide (NT-proBNP), red blood cell distribution width (RDW)], TCM syndrome score, and cardiac function indexes [left ventricular end diastolic internal diameter (LVEDD), left ventricular end systolic diameter (LVESD), and left ventricular ejection fraction (LVEF)] before and after treatment were compared between the two groups. 【Results】The total effective rate of the observation group was higher than the control group, and the difference was statistically significant (P<0.05). After treatment, the scores of shortness of breath, palpitation, cough, expectoration, and less breath and lazy words in the two groups were lower than those before treatment, and the observation group was lower than that in the control group, the difference was statistically significant (P<0.05); The levels of NT-proBNP, hs-CRP and RDW in the observation group were significantly lower than those before treatment and after treatment in the control group (P<0.05); LVEDD and LVESD of the two groups were lower than before treatment, LVEF was higher than before treatment, LVEDD and LVESD of the observation group were lower than those of the control group, LVEF was higher than that of the control group, the difference was statistically significant (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). 【Conclusion】On the basis of conventional western medicine treatment, the application of Guizhi Gancao Decoction in the treatment of chronic heart failure can improve the clinical treatment effect,improve cardiac function, with high safety, which is worthy of clinical application.
Key wordsHeart Failure/ ZJ    Chronic Disease    Treatment Outcome
收稿日期: 2022-11-21     
中图分类号:  R541.61  
引用本文:   
赵丽晨. 桂枝甘草汤联合常规西药治疗慢性心力衰竭患者的临床疗效[J]. 医学临床研究, 2024, 41(4): 579-582.
ZHAO Lichen. Clinical Efficacy of Guizhi Gancao Decoction Combined with Conventional Western Medicine in the Treatment of Patients with Chronic Heart Failure. JOURNAL OF CLINICAL RESEARCH, 2024, 41(4): 579-582.
链接本文:  
http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2024.04.028     或     http://journal07.magtech.org.cn/yxlcyj/CN/Y2024/V41/I4/579
版权所有 © 2013 医学临床研究杂志社  湘ICP备13012052号-1
办公地址:湖南省长沙市芙蓉区新军路43号煤炭大院主办公楼6楼621、623、632、636室 邮编:410011 电话(传真):0731-84824007 E-mail:jcr_cs.hn@vip.163.com
技术支持:北京玛格泰克科技发展有限公司 技术支持:support@magtech.com.cn